Computerised cognitive behavioural therapy (cCBT) with e-monitoring (oversight from clinicians provided electronically) for help seeking adolescents with depressive symptoms: clinical implementation trial to determine feasibility and acceptability.

Not Applicable

Completed

• Conditions: Depression; Anxiety; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12613000811707
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Participants will be eligible for inclusion if:
1. Present with low mood or depressive symptoms or if a clinician determines low mood/depressive symptoms to be the primary problem.
2. They are aged 12 to 19 years of age (on day of the consent);
3. Newly referred/presenting to the health clinic or existing clients interested in this additional intervention;
4. The consent process will follow usual practice at health clinic (and any other site that may be added to this study). Individual consent will be collected from all participants. Parental consent will be collected if a clinician deems it appropriate.
5. They have sufficient English language ability to understand the program;
6. Can access a computer and Internet to use SPARX paired with e-monitoring. This may be a home computer but if the staff at the health clinic choose to offer SPARX online at the clinic, this will be available too.

Exclusion Criteria

Participants will be ineligible in the study if:
1. They have severe depression, high suicide risk or other severe mental health issue which may mean that they are not safe to receive SPARX;
2. They have an intellectual disability or physical limitations that would result in them not being able to use the computer program
3. Currently is or has been receiving (past 3 months) CBT, interpersonal therapy or antidepressant medication

Study & Design

• Study Type: Interventional
• Study Design: Not specified